Yes, also for sites 3,4,5,and 6.
And don't forget that our methodology is to create best practice in production of the cannabinoids extraction and infusion into products, which are in line with both Canadian and U.S. pharma practice in drug production.
Were already set and ready to run with it once permission is given.
GLTA